December 4, 2022

U.S. Suspends J&J Covid-19 Vaccine Shipments as States Face a Surplus of Expiring Doses

The U.S. government has halted new shipments of the Johnson & Johnson Covid-19 vaccine, according to state and federal health officials, one of several steps federal agencies are taking that could help clear a backlog of unused doses before they expire.

The U.S. Centers for Disease Control and Prevention has stopped making available the one-dose shot to states, the state and federal health officials said. The stoppage is believed to be temporary, some of these officials said.

Health officials from Maryland, Oklahoma, Arkansas, Michigan, Illinois and other states said they haven’t been able to order new supplies of J&J doses in recent weeks. Some also said they have sufficient supply of the vaccine.

“It just hasn’t been included in our weekly allocations, from the feds, which means it is not available to order,” said Oklahoma State Department of Health Deputy Commissioner Keith Reed.

The move comes as the U.S. Food and Drug Administration separately extended the shelf life of J&J’s vaccine to 4½ months from three months once refrigerated, the drugmaker said Thursday.

A spokeswoman for the Arkansas state health department said it was informed that no doses were available for ordering because of issues related to the manufacturing of the vaccine.

It couldn’t be determined why the federal government suspended the shipments, but comes at a time when health officials are pushing for the use of stockpiled J&J doses prior to their expiration.

A J&J spokesman didn’t respond to a request for comment on the government’s decision to limit availability of its vaccine to states.

Just over half of the approximately 21 million of the J&J doses distributed in the U.S. have been administered, a lower percentage compared with shots from

Pfizer Inc.

and

Moderna Inc.,

according to the CDC.

Hospital and state officials said they have many J&J doses expiring later this month, partly as an unintended consequence of the U.S.’s decision in April to temporarily suspend administration of J&J doses to assess a rare blood-clot risk.

The pause forced states and providers to cancel large blocks of appointments that were never rescheduled and left a surplus of supply and, in some areas, increased hesitancy over the J&J vaccine’s safety.

The J&J vaccine was authorized by the U.S. Food and Drug Administration in February after researchers found it to be effective in a large-scale trial at protecting against symptomatic Covid-19.

While its efficacy was slightly lower than Pfizer and Moderna shots, public-health officials and vaccine experts had high hopes for the shot’s role in the vaccine drive—because it was a single-shot and required fewer cold-chain restrictions.

J&J stores doses frozen until shipment by the government, at which point they are refrigerated. That is when the countdown starts for expiration.

State health officials said they haven’t been able to order new doses of the J&J shot since mid-May. The CDC has been restricting orders of the J&J vaccine, the federal health official said.

Maryland last ordered J&J doses several weeks ago and has since been told by the government that the vaccine isn’t available, Maryland Department of Health Assistant Secretary Bryan Mroz said in an interview. Federal officials say J&J’s shot will become available again but didn’t say when that would be, he said.

“We’ve been using up our inventory in the state,” Mr. Mroz. “We definitely have more supply than demand.”

Mr. Mroz said that some doses will expire at the end of June and others in July and that the state is working to redistribute some to providers who request them.

States such as Wisconsin and Oklahoma have been asking the federal government for guidance on what to do with expiring doses.

For much of the rollout, states and providers had been instructed by states and the federal government to dispose of unused doses past their expiration date. Recently, some states say they have been getting conflicting information.

Mr. Mroz said in an interview that the CDC on Tuesday recommended the state put aside expiring J&J doses in storage as the agency waited to learn from federal government reviews into whether the shelf life can be extended. But he said the CDC then changed that guidance on Wednesday and suggested expired doses should still be discarded.

More on Covid Vaccination Effort

Write to Jared S. Hopkins at [email protected] and Betsy McKay at [email protected]

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Related Posts

Amazon’s Prime Day Is Earlier Than Usual This Year. Here’s When It Is and What to Expect.

June 21, 2021

June 21, 2021

This year’s Prime Day, running on Monday and Tuesday and a month earlier than it typically does, creates a likely...

Airlines Gird for Thanksgiving Travel Test After Rocky Year

November 20, 2021

November 20, 2021

Thanksgiving will test whether airlines have done enough to insulate their operations from shocks that have roiled air travel in...

United Plans to Buy 15 Supersonic Planes

June 3, 2021

June 3, 2021

United Airlines said it hopes to fly passengers on a planned new supersonic jetliner by the end of the decade....

Lordstown Motors Looks to Reset Its Course a Day After CEO’s Exit

June 15, 2021

June 15, 2021

Executives at troubled electric-truck startup Lordstown Motors Corp. said Tuesday that the company has enough interest from potential buyers to...

U.S. Budget Deficit Grew to Record $2.1 Trillion in Fiscal Year’s First Eight Months

June 10, 2021

June 10, 2021

The U.S. budget deficit grew to a record $2.1 trillion during the first eight months of the fiscal year as...

Alibaba Falls Victim to Chinese Web Crawler in Large Data Leak

June 16, 2021

June 16, 2021

A Chinese software developer trawled Alibaba Group Holding Ltd. ’s popular Taobao shopping website for eight months, clandestinely collecting more...

Biden Administration to Give Hospitals More Time to Spend Covid-19 Relief Money

June 11, 2021

June 11, 2021

Congress approved about $187 billion in several spending bills dating to the Trump administration to help hospitals recover losses related...

J&J Covid-19 Vaccine Shows Promising Preliminary Signs of Protecting Against Delta Variant

July 2, 2021

July 2, 2021

Johnson & Johnson ’s Covid-19 vaccine showed promising signs in a small laboratory study of protecting against the Delta variant...

China’s Tech Clampdown Is Spreading

June 6, 2021

June 6, 2021

TAIPEI—The latest salvos in China’s campaign against its tech companies make one thing clear: Jack Ma’s businesses aren’t the only...

U.S.-China Tech Fight Opens New Front in Ethiopia

May 22, 2021

May 22, 2021

A U.S.-backed consortium beat out one financed by China in a closely watched telecommunications auction in Ethiopia—handing Washington a victory...

Venmo to Charge Users for Selling Goods and Services

June 26, 2021

June 26, 2021

Venmo, the payments app owned by PayPal Holdings Inc., PYPL -1.23% will soon allow users to sell products and services...

China’s Campaign Against H&M Divides Fashion Industry Group

May 22, 2021

May 22, 2021

LONDON—A debate over how much to push back against the Chinese government has set off a conflict inside a prominent...

AstraZeneca Covid-19 Antibody Treatment Suffers Setback

June 15, 2021

June 15, 2021

AstraZeneca PLC’s coronavirus antibody treatment failed in late-stage clinical trials to achieve its primary goal of preventing symptomatic Covid-19 in...

Pfizer Suspends Global Distribution of Chantix Smoking-Cessation Pill on Contamination Concerns

June 25, 2021

June 25, 2021

Pfizer Inc. PFE 0.03% has suspended distribution world-wide of antismoking pill Chantix and recalled some lots after finding they contained...

JBS Paid $11 Million to Resolve Ransomware Attack

June 9, 2021

June 9, 2021

JBS USA Holdings Inc. paid an $11 million ransom to cybercriminals who last week temporarily knocked out plants that process...